Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parentheticals)

v3.23.3
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Deferred tax assets ($1.0 million and $1.0 million attributable to VIE) $ 11,741,090 $ 11,928,152
Payroll liabilities 3,875,453 2,030,510
Deferred revenue from company clinics attributable to VIE 2,512,350 2,468,601
Other liabilities ($1.3 million and $1.3 million attributable to VIE) $ 1,287,880 $ 1,287,879
Series A preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Series A preferred stock, shares authorized (in shares) 50,000 50,000
Series A preferred stock, shares issued (in shares) 0 0
Series A preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 20,000,000 20,000,000
Common stock, shares issued (in shares) 14,786,411 14,560,353
Common stock, shares outstanding (in shares) 14,754,287 14,528,487
Treasury stock, shares (in shares) 32,124 31,866
Variable Interest Entity, Primary Beneficiary    
Deferred tax assets ($1.0 million and $1.0 million attributable to VIE) $ 1,000,000.0 $ 1,000,000.0
Payroll liabilities 952,854 586,960
Deferred revenue from company clinics attributable to VIE 4,553,228 4,702,044
Other liabilities ($1.3 million and $1.3 million attributable to VIE) $ 1,300,000 $ 1,300,000